Cited by 80Pregnancy and preeclampsia studiesEstrogen and related hormone effectsReproductive System and Pregnancy

The Human Placenta Expresses CYP17 and Generates Androgens De Novo

Escobar, J. C., Patel, S. S., Beshay, V. E., Suzuki, T., Carr, B. R.·2011·The Journal of Clinical Endocrinology & Metabolism

Abstract

INTRODUCTION: The human placenta is believed to have insignificant CYP17 expression, rendering it dependent on the maternal and fetal compartments for the necessary androgenic precursors to yield the high levels of estrogens seen in pregnancy. OBJECTIVE: The aim of the study was to analyze whether the human trophoblast is capable of expressing CYP17 and producing androgens de novo. METHODS: Human trophoblasts from fresh placentas and JEG-3 cells were used for all experiments. CYP17 mRNA analysis was performed via RT-PCR, and protein detection by Western blot and immunohistochemical staining. Steroid products were quantified using RIAs. RESULTS: CYP17 mRNA was expressed in both cell types. CYP17 protein was detected by Western blotting and localized by immunostaining mainly to the cytoplasm of syncytiotrophoblasts. Measurement of 17α-hydroxyprogesterone, androstenedione, and their aromatized products in the media further demonstrated CYP17 expression and activity in the human trophoblast. Baseline levels of CYP17 steroid products were higher in primary cells and significantly increased in the presence of 22-hydroxycholesterol. CONCLUSIONS: We have demonstrated CYP17 mRNA and protein expression and activity in human trophoblasts. Considering the precursor concentration, blood flow, and mass of the placenta, we suggest that its contribution of androgens is an important source of estrogen production in pregnancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-2504

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CYP17A1 activity is sufficient for the production of T, E1 and E2, as demonstrated for trophoblasts.

    “However, CYP17A1 activity is sufficient for the production of T, E1 and E2, as has been demonstrated for trophoblasts (Escobar et al., 2011).”

    From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Escobar et al., 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Carr BR 2001 The maternal-fetal-placental unit. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. 3rd ed. Chap 108. Philadelphia: J. B. Lippincott, Williams and Wilkins; 1059 -1072

Cited by

Sorted by citations

Authors
Escobar, J. C., Patel, S. S., Beshay, V. E., Suzuki, T., & Carr, B. R.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Tohoku University (JP)
Corresponding author
Carr, B. R.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-05
Volume
96
Issue
5
Pages
1385-1392
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1977514238
Cited by
80
References
36
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 10 · 2013: 1 · 2012: 4
FWCI
6.59
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
CYP17, human placenta, trophoblast, syncytiotrophoblast, 17-hydroxyprogesterone, androstenedione, 22-hydroxycholesterol, JEG-3 cells, placental steroidogenesis
MeSH terms
Adrenal Cortex Hormones, Adult, Androgens, Anencephaly, Cell Line, Cells, Cultured, Culture Media, Female, Fetal Death, Humans, Hydroxycholesterols, Immunohistochemistry, Placenta, Pregnancy, RNA, Messenger, Steroid 17-alpha-Hydroxylase, Steroids, Sulfatases, Trophoblasts, Blotting, Western, Gene Expression Regulation, Enzymologic, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review